Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis

Ítems similars

• Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
  per: Armstrong, M, et al.
  Publicat: (2014)
• Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis.
  per: Armstrong, M, et al.
  Publicat: (2014)
• Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
  per: Armstrong, M, et al.
  Publicat: (2013)
• Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo.
  per: Hazlehurst, J, et al.
  Publicat: (2013)
• Orlistat for overweight subjects with nonalcoholic steatohepatitis.
  per: Dowman, J, et al.
  Publicat: (2009)